肝癌与铁死亡的研究进展
Research Advancements in Hepatocellular Carcinoma and Ferroptosis
DOI: 10.12677/ACM.2022.12101354, PDF,   
作者: 李林俞, 陈 鑫:甘肃中医药大学第一临床医学院,甘肃 兰州;甘肃省人民医院肿瘤内科,甘肃 兰州;李红玲*:甘肃省人民医院肿瘤内科,甘肃 兰州
关键词: 肝癌席夫碱配体衍生物铁死亡P53Hepatocellular Carcinoma Schiff Base Ligand Derivative Ferroptosis P53
摘要: 肝细胞肝癌(hepatocellular carcinoma, HCC)是世界范围内最常见的恶性肿瘤之一。最新的数据显示,HCC发病率排位已上升至第六位,死亡率更是高达第三位。我国是一个乙肝大国,肝硬化是乙肝患者的终末期状态,HCC更是导致肝硬化患者死亡的最主要的原因。多年来,关于索拉非尼诱导肿瘤细胞死亡模式的研究层出不穷,过去人们更倾向于认为这种模式是细胞凋亡。然而最新研究已经证实,由索拉非尼诱导肝癌细胞死亡的模式是铁死亡,而不是凋亡。这给我们探索治疗HCC开启了新的研究方向。
Abstract: In the world, hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors. Ac-cording to the most recent data, the incidence of HCC has increased to the sixth spot, while the fatal-ity rate has reached the third spot. China has a high hepatitis B prevalence. Hepatitis B patients who have liver cirrhosis have reached the end stage of the disease, and HCC is the primary killer of peo-ple with liver cirrhosis. Numerous researches have been done over the years on the manner of so-rafenib-induced tumor cell death, which was formerly more frequently referred to as apoptosis. Recent research, however, has demonstrated that ferroptosis, as opposed to apoptosis, is the mode of liver cancer cell death brought on by sorafenib. This opens a new research direction for us to ex-plore the treatment of HCC.
文章引用:李林俞, 陈鑫, 李红玲. 肝癌与铁死亡的研究进展[J]. 临床医学进展, 2022, 12(10): 9363-9368. https://doi.org/10.12677/ACM.2022.12101354

参考文献

[1] Bian, X., Liu, R., Meng, Y., Xing, D., Xu, D. and Lu, Z. (2021) Lipid Metabolism and Cancer. Journal of Experimental Medicine, 218, e20201606. [Google Scholar] [CrossRef] [PubMed]
[2] Louandre, C., Marcq, I., Bouhlal, H., et al. (2015) The Retinoblastoma (Rb) Protein Regulates Ferroptosis Induced by Sorafenib in Human Hepatocellular Carcino-ma Cells. Cancer Letters, 356, 971-977. [Google Scholar] [CrossRef] [PubMed]
[3] Perusina Lanfranca, M., Thompson, J.K., Bednar, F., Halbrook, C., Lyssiotis, C., Levi, B. and Frankel, T.L. (2019) Metabolism and Epigenetics of Pancreatic Cancer Stem Cells. Semi-nars in Cancer Biology, 57, 19-26. [Google Scholar] [CrossRef] [PubMed]
[4] Beloribi-Djefaflia, S., Vasseur, S. and Guillaumond, F. (2016) Lipid Metabolic Reprogramming in Cancer Cells. Oncogenesis, 5, e189. [Google Scholar] [CrossRef] [PubMed]
[5] Dirat, B., Bochet, L., Dabek, M., Daviaud, D., Dauvillier, S., Majed, B., Wang, Y.Y., Meulle, A., Salles, B., Le Gonidec, S., Garrido, I., Escourrou, G., Valet, P. and Muller, C. (2011) Can-cer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion. Cancer Research, 71, 2455-2465. [Google Scholar] [CrossRef
[6] Epstein, T., Xu, L., Gillies, R.J. and Gatenby, R.A. (2014) Separation of Metabolic Supply and Demand: Aerobic Glycolysis as a Normal Physiological Response to Fluctuating Energetic Demands in the Membrane. Cancer & Metabolism, 2, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
[7] Li, L. and Li, W. (2015) Epithelial-Mesenchymal Transition in Human Cancer: Comprehensive Reprogramming of Metabolism, Epigenetics, and Differentiation. Pharmacology & Therapeutics, 150, 33-46. [Google Scholar] [CrossRef] [PubMed]
[8] Yu, X.H., Ren, X.H., Liang, X.H. and Tang, Y.L. (2018) Roles of Fatty Acid Metabolism in Tumourigenesis: Beyond Providing Nutrition (Review). Molecular Medicine Reports, 18, 5307-5316. [Google Scholar] [CrossRef] [PubMed]
[9] Ventura, R., Mordec, K., Waszczuk, J., Wang, Z., Lai, J., Fridlib, M., Buckley, D., Kemble, G. and Heuer, T.S. (2015) Inhibition of de Novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Re-programming Gene Expression. EBioMedicine, 2, 808-824. [Google Scholar] [CrossRef] [PubMed]
[10] Fhu, C.W. and Ali, A. (2020) Fatty Acid Synthase: An Emerging Target in Cancer. Molecules, 25, Article No. 3935. [Google Scholar] [CrossRef] [PubMed]
[11] Ladanyi, A., Mukherjee, A., Kenny, H.A., et al. (2018) Adipo-cyte-Induced CD36 Expression Drives Ovarian Cancer Progression and Metastasis. Oncogene, 37, 2285-2301. [Google Scholar] [CrossRef] [PubMed]
[12] Pan, J., Fan, Z., Wang, Z., Dai, Q., Xiang, Z., Yuan, F., Yan, M., Zhu, Z., Liu, B. and Li, C. (2019) CD36 Mediates Palmitate Acid-Induced Metastasis of Gastric Cancer via AKT/GSK-3β/β-Catenin Pathway. Journal of Experimental & Clinical Cancer Research, 38, Article No. 52. [Google Scholar] [CrossRef] [PubMed]
[13] Liang, Y., Han, H., Liu, L., et al. (2018) CD36 Plays a Critical Role in Proliferation, Migration and Tamoxifen-Inhibited Growth of ER-Positive Breast Cancer Cells. Oncogenesis, 7, Article No. 98. [Google Scholar] [CrossRef] [PubMed]
[14] Nath, A., Li, I., Roberts, L.R. and Chan, C. (2015) Elevated Free Fatty Acid Uptake via CD36 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Scientific Re-ports, 5, Article No. 14752. [Google Scholar] [CrossRef] [PubMed]
[15] Nath, A. and Chan, C. (2016) Genetic Alterations in Fatty Acid Transport and Metabolism Genes Are Associated with Metastatic Progression and Poor Prognosis of Human Cancers. Scientific Reports, 6, Article No. 18669. [Google Scholar] [CrossRef] [PubMed]
[16] Svegliati-Baroni, G., Pierantonelli, I., Torquato, P., Marinelli, R., Ferreri, C., Chatgilialoglu, C., Bartolini, D. and Galli, F. (2019) Lipidomic Biomarkers and Mechanisms of Lipotoxicity in Non-Alcoholic Fatty Liver Disease. Free Radical Biology & Medicine, 144, 293-309. [Google Scholar] [CrossRef] [PubMed]
[17] Zhu, A.X., Finn, R.S., Edeline, J., Cattan, S., Ogasawara, S., Palmer, D., Verslype, C., Zagonel, V., Fartoux, L., Vogel, A., Sarker, D., Verset, G., Chan, S.L., Knox, J., Daniele, B., Webber, A.L., Ebbinghaus, S.W., Ma, J., Siegel, A.B., Cheng, A.L., Kudo, M. and KEYNOTE-224 Investigators (2018) Pembrolizumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib (Key-note-224): A Non-Randomised, Open-Label Phase 2 Trial. The Lancet Oncology, 19, 940-952.
[18] Giraud, J., Chalop-in, D., Blanc, J.F. and Saleh, M. (2021) Hepatocellular Carcinoma Immune Landscape and the Potential of Immunothera-pies. Frontiers in Immunology, 12, Article ID: 655697. [Google Scholar] [CrossRef] [PubMed]
[19] Bray, S.J. (2016) Notch Signalling in Context. Nature Reviews Molecular Cell Biology, 17, 722-735. [Google Scholar] [CrossRef] [PubMed]
[20] Li, S., Brown, M.S. and Goldstein, J.L. (2010) Bifurcation of Insulin Signaling Pathway in Rat Liver: mTORC1 Required for Stimulation of Lipogenesis, but Not Inhibition of Gluconeogene-sis. Proceedings of the National Academy of Sciences of the United States of America, 107, 3441-3446. [Google Scholar] [CrossRef] [PubMed]
[21] Talukdar, S., Oh, D.Y., Bandyopadhyay, G., et al. (2012) Neutro-phils Mediate Insulin Resistance in Mice Fed a High-Fat Diet through Secreted Elastase. Nature Medicine, 18, 1407-1412. [Google Scholar] [CrossRef] [PubMed]
[22] Miyachi, Y., Tsuchiya, K., Komiya, C., Shiba, K., Shimazu, N., Yamaguchi, S., Deushi, M., Osaka, M., Inoue, K., Sato, Y., Matsumoto, S., Kikuta, J., Wake, K., Yoshida, M., Ishii, M. and Ogawa, Y. (2017) Roles for Cell-Cell Adhesion and Contact in Obesity-Induced Hepatic Myeloid Cell Accumulation and Glu-cose Intolerance. Cell Reports, 18, 2766-2779. [Google Scholar] [CrossRef] [PubMed]
[23] Lee, U., Cho, E.Y. and Jho, E.H. (2022) Regulation of Hippo Signaling by Metabolic Pathways in Cancer. Biochimica et Biophysica Ac-ta—Molecular Cell Research, 1869, Article ID: 119201. [Google Scholar] [CrossRef] [PubMed]
[24] Aylon, Y., Gershoni, A., Rotkopf, R., Biton, I.E., Porat, Z., Koh, A.P., Sun, X., Lee, Y., Fiel, M.I., Hoshida, Y., Friedman, S.L., Johnson, R.L. and Oren, M. (2016) The LATS2 Tumor Suppressor Inhibits SREBP and Suppresses Hepatic Cholesterol Accumulation. Genes & Development, 30, 786-797. [Google Scholar] [CrossRef] [PubMed]
[25] Wang, X., Cai, B., Yang, X., Sonubi, O.O., Zheng, Z., Ra-makrishnan, R., Shi, H., Valenti, L., Pajvani, U.B., Sandhu, J., Infante, R.E., Radhakrishnan, A., Covey, D.F., Guan, K.L., Buck, J., Levin, L.R., Tontonoz, P., Schwabe, R.F. and Tabas, I. (2020) Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-Alcoholic Steatohepatitis. Cell Metabolism, 31, 969-986.e7. [Google Scholar] [CrossRef] [PubMed]
[26] Wei, H., Li, J., Shi, S., Zhang, L., Xiang, A., Shi, X., Yang, G. and Chu, G. (2019) Hhip Inhibits Proliferation and Promotes Differentiation of Adipocytes through Suppressing Hedgehog Signaling Pathway. Biochemical and Biophysical Research Communications, 514, 148-156. [Google Scholar] [CrossRef] [PubMed]
[27] Bagchi, D.P. and MacDougald, O.A. (2021) Wnt Signaling: From Mesenchymal Cell Fate to Lipogenesis and Other Mature Adipocyte Functions. Diabetes, 70, 1419-1430. [Google Scholar] [CrossRef] [PubMed]
[28] Anderson, C.M. and Macleod, K.F. (2019) Autophagy and Cancer Cell Metabolism. International Review of Cell and Molecular Biology, 347, 145-190. [Google Scholar] [CrossRef] [PubMed]
[29] Singh, R., Kaushik, S., Wang, Y., et al. (2009) Autophagy Reg-ulates Lipid Metabolism. Nature, 458, 1131-1135. [Google Scholar] [CrossRef] [PubMed]
[30] Tang, Q., Su, Z., Gu, W., et al. (2020) Mutant p53 on the Path to Metas-tasis. Trends in Cancer, 6, 62-73. [Google Scholar] [CrossRef] [PubMed]
[31] Zhang, C., Liu, J., Xu, D., et al. (2020) Gain-of-Function Mutant p53 in Cancer Progression and Therapy. Journal of Molecular Cell Biology, 12, 674-687. [Google Scholar] [CrossRef] [PubMed]
[32] Li, D. and Li, Y. (2020) The Interaction between Ferroptosis and Lipid Metabolism in Cancer. Signal Transduction and Targeted Therapy, 5, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
[33] Bai, Y., Meng, L., Han, L., Jia, Y., Zhao, Y., Gao, H., Kang, R., Wang, X., Tang, D. and Dai, E. (2019) Lipid Storage and Lipophagy Regulates Ferroptosis. Biochemical and Biophysical Research Communications, 508, 997-1003. [Google Scholar] [CrossRef] [PubMed]
[34] Snaebjornsson, M.T., Janaki-Raman, S. and Schulze, A. (2020) Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metabolism, 31, 62-76. [Google Scholar] [CrossRef] [PubMed]
[35] Koundouros, N. and Poulogiannis, G. (2020) Reprogramming of Fatty Acid Metabolism in Cancer. British Journal of Cancer, 122, 4-22. [Google Scholar] [CrossRef] [PubMed]
[36] Pascual, G., Avgustinova, A., Mejetta, S., Martín, M., Castellanos, A., Attolini, C.S., Berenguer, A., Prats, N., Toll, A., Hueto, J.A., Bescós, C., Di Croce, L. and Benitah, S.A. (2017) Targeting Metastasis-Initiating Cells through the Fatty Acid Receptor CD36. Nature, 541, 41-45. [Google Scholar] [CrossRef] [PubMed]
[37] Holthuis, J.C. and Menon, A.K. (2014) Lipid Landscapes and Pipelines in Membrane Homeostasis. Nature, 510, 48-57. [Google Scholar] [CrossRef] [PubMed]
[38] Efeyan, A., Comb, W.C. and Sabatini, D.M. (2015) Nutrient-Sensing Mechanisms and Pathways. Nature, 517, 302-310. [Google Scholar] [CrossRef] [PubMed]